<code id='829B996CE2'></code><style id='829B996CE2'></style>
    • <acronym id='829B996CE2'></acronym>
      <center id='829B996CE2'><center id='829B996CE2'><tfoot id='829B996CE2'></tfoot></center><abbr id='829B996CE2'><dir id='829B996CE2'><tfoot id='829B996CE2'></tfoot><noframes id='829B996CE2'>

    • <optgroup id='829B996CE2'><strike id='829B996CE2'><sup id='829B996CE2'></sup></strike><code id='829B996CE2'></code></optgroup>
        1. <b id='829B996CE2'><label id='829B996CE2'><select id='829B996CE2'><dt id='829B996CE2'><span id='829B996CE2'></span></dt></select></label></b><u id='829B996CE2'></u>
          <i id='829B996CE2'><strike id='829B996CE2'><tt id='829B996CE2'><pre id='829B996CE2'></pre></tt></strike></i>

          entertainment

          entertainment

          author:fashion    Page View:1853
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more
          Can U.S. cancer drug shortages be fixed?
          Can U.S. cancer drug shortages be fixed?

          AdobeRoughlytwomillionAmericansareexpectedtoreceiveacancerdiagnosisthisyear.Somemembersofthisalready

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          How the first Native Hawaiian psychiatrist helped diversify medicine

          BenYoungblowingaconchshellonaround-the-worldcanoetripin2017.BenjaminB.YoungBenjaminYoungdidn’tsetout